Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells
- PMID: 14707268
Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells
Abstract
Interactions between histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), also known as Apo2 ligand, were examined in human leukemia cells (e.g., U937, Jurkat, and HL-60). Simultaneous exposure of cells to 100-ng/ml TRAIL with either 1-mM sodium butyrate or 2- micro M suberoylanilide hydroxamic acid resulted in a striking increase in leukemic cell mitochondrial damage, caspase activation, and apoptosis. Lethal effects were significantly diminished in U937 cells ectopically expressing dominant-negative caspase-8, dominant-negative Fas-associated death domain, CrmA (receptor pathway), or Bcl-2 or Bcl-X(L) (mitochondrial pathway). Analysis of mitochondrial events in U937 cells exposed to TRAIL/HDAC inhibitors revealed enhanced Bid activation and Bax translocation, loss of mitochondrial membrane potential, and cytoplasmic release of cytochrome c, Smac/DIABLO, and apoptosis-inducing factor. No changes were observed in expression of FLICE-like inhibitory protein, TRAIL receptors, or reactive oxygen species generation. TRAIL/HDAC inhibitor-induced apoptosis triggered caspase-dependent cleavage of p21(WAF1/CIP1); moreover, enforced expression of a nuclear localization signal deletant form of p21(WAF1/CIP1) significantly diminished lethality. Lastly, p27(KIP1), pRb, X-linked inhibitor of apoptosis, and Bcl-2 displayed extensive proteolysis. These findings indicate that coadministration of TRAIL with HDAC inhibitors synergistically induces apoptosis in human myeloid leukemia cells and provide further evidence that simultaneous activation of the extrinsic and intrinsic pathways in such cells leads to a dramatic increase in mitochondrial injury and activation of the caspase cascade.
Similar articles
-
Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation.Leukemia. 2004 Nov;18(11):1780-8. doi: 10.1038/sj.leu.2403491. Leukemia. 2004. PMID: 15385934
-
Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways.Int J Mol Med. 2005 Dec;16(6):1125-38. Int J Mol Med. 2005. PMID: 16273296
-
The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells.Cancer Res. 2004 Apr 1;64(7):2590-600. doi: 10.1158/0008-5472.can-03-2631. Cancer Res. 2004. PMID: 15059916
-
The histone deacetylase inhibitor suberic bishydroxamate: a potential sensitizer of melanoma to TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis.Biochem Pharmacol. 2003 Oct 15;66(8):1537-45. doi: 10.1016/s0006-2952(03)00509-4. Biochem Pharmacol. 2003. PMID: 14555232 Review.
-
Shared pathways: death receptors and cytotoxic drugs in cancer therapy.Pathol Oncol Res. 2001;7(2):95-106. doi: 10.1007/BF03032574. Pathol Oncol Res. 2001. PMID: 11458271 Review.
Cited by
-
Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways.Autophagy. 2015 Apr 3;11(4):629-42. doi: 10.1080/15548627.2015.1023981. Autophagy. 2015. PMID: 25919885 Free PMC article.
-
Anticancer potential of the histone deacetylase inhibitor-like effects of flavones, a subclass of polyphenolic compounds: a review.Mol Biol Rep. 2015 Nov;42(11):1515-31. doi: 10.1007/s11033-015-3881-y. Epub 2015 Jun 2. Mol Biol Rep. 2015. PMID: 26033434 Review.
-
HDAC inhibitor-based therapies: can we interpret the code?Mol Oncol. 2012 Dec;6(6):637-56. doi: 10.1016/j.molonc.2012.09.003. Epub 2012 Oct 23. Mol Oncol. 2012. PMID: 23141799 Free PMC article. Review.
-
Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor.Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15540-5. doi: 10.1073/pnas.0607518103. Epub 2006 Oct 9. Proc Natl Acad Sci U S A. 2006. PMID: 17030815 Free PMC article.
-
Histone deacetylase inhibitor PCI-24781 enhances chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell lines.Anticancer Res. 2011 Apr;31(4):1115-23. Anticancer Res. 2011. PMID: 21508354 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous